{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-006239","form_type":"8-K","ticker":"OFIX","cik":"0000884624","company_name":"Orthofix Medical Inc.","filed_at":"2023-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.386979+00:00","generated_at":"2026-06-18T12:28:20.610278+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Orthofix reports Q4 2022 results; SeaSpine merger closed Jan 5; combined 2023 guidance $743-753M","bullets":["Orthofix stand-alone Q4 net sales $122.2M (-2% reported, flat constant currency); net loss $7.1M vs $32.8M loss prior year.","SeaSpine stand-alone Q4 net sales $63.4M (+14% YoY); net loss $19.0M vs $18.8M loss prior year.","Combined company expects Q1 2023 net sales $166-170M and full-year 2023 net sales $743-753M.","Merger of Orthofix and SeaSpine completed January 5, 2023; results do not include merger accounting adjustments.","Orthofix borrowed $45M under credit facility in Jan/Mar 2023 to fund merger expenses and working capital."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-006239","json":"https://secwatch.observer/filing/0000950170-23-006239.json","markdown":"https://secwatch.observer/filing/0000950170-23-006239.md","text":"https://secwatch.observer/filing/0000950170-23-006239.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/884624/000095017023006239/0000950170-23-006239-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/884624/000095017023006239/ofix-20230306.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T12:28:20.610278+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f72257d131bbd434e510cdab5c7385550b0e08d9","claim":"Orthofix Medical Inc. reported financial results for fourth quarter and full year ended December 31, 2022.","evidence_excerpt":"On March 6, 2023, Orthofix Medical Inc. (the “Company”) issued a news release announcing, among other things, its financial results for the fourth quarter and year ended December 31, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/884624/000095017023006239/0000950170-23-006239-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter and full year ended December 31, 2022"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}